Search Results - "Filippidou, Natalia"
-
1
Rapalog resistance is associated with mesenchymal-type changes in Tsc2-null cells
Published in Scientific reports (28-02-2019)“…Tuberous Sclerosis Complex (TSC) and Lymphangioleiomyomatosis (LAM) are caused by inactivating mutations in TSC1 or TSC2 , leading to mTORC1 hyperactivation…”
Get full text
Journal Article -
2
Mechanisms of activation induced by antiphospholipid antibodies in multiple sclerosis: Potential biomarkers of disease?
Published in Journal of immunological methods (01-11-2019)“…Multiple sclerosis (MS) is a chronic, multifactorial, inflammatory disease of the central nervous system where demyelination leads to neurodegeneration and…”
Get full text
Journal Article -
3
Abstract 3022: Dissecting rapamycin resistance in a Tsc2-null rat leiomyoma cell line developed in a murine xenograft
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Despite the identification of mTOR hyperactivation as the main biochemical defect downstream of TSC1/TSC2 inactivation in Lymphangioleiomyomatosis (LAM) and…”
Get full text
Journal Article -
4
Exploration of isatin-based inhibitors of SARS-CoV-2 Nsp15 endoribonuclease
Published in European journal of medicinal chemistry (05-12-2024)“…The global health crisis caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) urges the development of new antiviral agents with broad…”
Get full text
Journal Article -
5
The possible role of an autoimmune mechanism in the etiopathogenesis of Parkinson’s disease
Published in Journal of clinical neuroscience (01-08-2018)“…•Anti-PS and anti-dsDNA antibodies were elevated in PD patients.•The presence of these autoantibodies is not analogous with increased levels of oxidative…”
Get full text
Journal Article -
6
The association between IgG and IgM antibodies against cardiolipin, β2-glycoprotein I and Domain I of β2-glycoprotein I with disease profile in patients with multiple sclerosis
Published in Molecular immunology (01-07-2016)“…•First study to identify anti-domain I antibodies in multiple sclerosis patients.•Anti-cardiolipin antibodies were raised in secondary progressive multiple…”
Get full text
Journal Article -
7
The association between IgG and IgM antibodies against cardiolipin, beta 2-glycoprotein I and Domain I of beta 2-glycoprotein I with disease profile in patients with multiple sclerosis
Published in Molecular immunology (01-07-2016)“…Antiphospholipid antibodies (aPL) occur in patients with multiple sclerosis (MS) with a number of studies reporting elevated levels; their exact prevalence and…”
Get full text
Journal Article